Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 205 results for "lupin"

Lupin gets FDA approval for its generic drug
India Infoline

Lupin gets USFDA nod for generic cough relief oral solution

Drug firm Lupin has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution used for providing relief of cough. DNA, 6 days ago
Lupin gets FDA approval for its generic drug India Infoline, 2 weeks ago
[x]  

244 images for lupin

Money Control, 1 week ago
Money Control, 2 days ago
Sify, 1 week ago
Reuters, 1 week ago
DNA, 1 week ago
Financial Express, 2 weeks ago
India Infoline, 1 week ago
Pharmaceutical Tech.com, 2 weeks ago
Anime News Network, 2 weeks ago
Anime News Network, 2 weeks ago
Money Control

Reliance Securities stock picks: Lupin, Tata Motors, Adani Ports

We believe Tata Motors will soon reverse to recover prior losses after taking support at around Rs 430. The pharma sector also has seen sharp up move and we believe the Lupin risk reward is very favorable
 Money Control2 days ago
Sify

Lupin Q3 net up 20.68% at Rs 633.1 cr

Pharmaceutical firm Lupin Ltd today reported 20.68 per cent increase in consolidated net profit at Rs 633.1 crore for the third quarter ended December 31, 2016, driven by robust sales in North American market. The company had posted a consolidated net profit ...
 Business Standard1 week ago Lupin up after reporting near 21% Y-o-Y jump in net profit  Sify1 week ago Lupin Q3 net profit rises 21% to Rs 633 crore on strong US sales  Money Control1 week ago Lupin's Q3 net up by 21 per cent  Prokerala1 week ago
DNA

Lupin Pharma eyes launch of 25 products in the US next fiscal

However, the drugmaker said its revenue may be neutral as its competitors were planning the launch of rival products in its key categories.
 DNA1 week ago Lupin eyes launch of 25 products in the US in FY18  Business Standard1 week ago
Money Control

Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue

According to average of estimates of analysts polled by CNBC-TV18, operating profit is expected to jump 15.3 percent to Rs 1,011.7 crore but margin may shrink 70 basis points to 24 percent on yearly basis.
 Money Control1 week ago Lupin posts better-than-expected Q3 profit as US sales rise  Business Standard1 week ago Lupin Q3 profit up 21 pct, beats estimate  Business Standard1 week ago

EXCLUSIVE: Over 25 new launches lined up for FY18: Lupin Chief

In an exclusive interview with Moneycontrol’s Malini Bhupta, Lupin’s CEO Vinita Gupta says the next year will be good thanks to 25 new product launches.
 Money Control1 week ago

Results to watch out for! Lupin, Power Grid Corp, Aurobindo Pharma in focus

The results which are expected today are Lupin, Power Grid Corp, SAIL, Cairn India, Aurobindo Pharma, BOI, Andhra Bank, Bajaj Electricals, LT Foods, Escorts, JBM Auto, NCC.
 India Infoline1 week ago ABB, Bata, Cairn, JK Tyre, Lupin results  Business Line2 weeks ago
Reuters

Drugmaker Lupin posts strong Q3; warns competition to drag next year

MUMBAI (Reuters) - Indian drugmaker Lupin Ltd reported a better-than-expected quarterly profit, helped by higher sales of its diabetes products in the United States, but cautioned growth in the next fiscal year would be muted due to rising competition.
 Reuters1 week ago
India Infoline

Lupin, DLF and Tech Mahindra see long built up in their February futures

News Service | Mumbai | February 09, 2017 14:22 IST Following stock future contracts of February series recorded strong long built up position in Thursday’s trading session:
 India Infoline1 week ago
Rediff.com

Strong US portfolio boost for Lupin

Market share gains in the US led to higher operating or underlying profit
 Business Standard1 week ago Indian Indices Trade Marginally Lower; Metal Stocks Witness Selling  Equitymaster.com1 week ago Market gains for 3rd session; pharma stocks hold back  Rediff.com1 month ago Indian Markets Open Marginally Higher; Pharma & Power Stocks Lead  Equitymaster.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less